Abstract: The present invention relates to processes and agents for combating fleas on, and in the surroundings of, domestic animals, which is characterised in that the domestic animals are treated with collars which contain active compounds which inhibit insect development.
Type:
Grant
Filed:
July 14, 1992
Date of Patent:
November 30, 1993
Assignee:
Bayer Aktiengesellschaft
Inventors:
Wilhelm Stendel, Reiner Pospischil, Herbert Voege
Abstract: Herbicidal compounds of the formula ##STR1## in which R.sup.1 stands for halogen, cyano or trifluoromethyl,R.sup.2 stands for hydrogen or halogen,R.sup.3 stands for halogen, trifluoromethyl, trifluoromethoxy, trifluoromethylthio or trifluoromethylsulphonyl,R.sup.4 stands for hydrogen or halogen,X stands for nitrogen or for the grouping C-R.sup.5,whereR.sup.5 stands for hydrogen or halogen,with the proviso that at least one of the substituents R.sup.2 or R.sup.4 is different from hydrogen if R.sup.1 stands for chlorine or cyano and simultaneously R.sup.3 stands for trifluoromethyl and X stands for CH, and that R.sup.
Type:
Grant
Filed:
September 16, 1988
Date of Patent:
August 20, 1991
Assignee:
Bayer Aktiengesellschaft
Inventors:
Michael Haug, Roland Andree, Hans-Joachim Santel, Robert R. Schmidt, Harry Strang
Abstract: Fungicidal cyclopropanoylamino acid amide derivative of the formula ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are identical or different and represent hydrogen or alkyl;Q represents an unsubstituted or substituted straight-chain or branched alkylene chain, or together with the radical R.sup.4 and the nitrogen atom forms a pyrrolidine ring;A represents a straight-chain or branched alkylene chain;n represents the number 0 or 1 andAr represents unsubstituted or substituted aryl.
Abstract: In the preparation of 2-chloro-5-methylpyridine of the formula ##STR1## by reacting 3-methylpyridine 1-oxide with phosphorus oxychloride, the improvement which comprises carrying out the reaction in the presence of a basic organic nitrogen compound and in the presence of a diluent at a temperature between about -50.degree. C. and +50.degree. C.
Abstract: The invention provides pure enatiomers of 4,5-disubstituted .gamma.-butyrolactams of the general formula ##STR1## By means of the pure enantiomers of 4,5-disubstituted .gamma.-butyrolactams (I), according to the invention, it is now possible to synthesize (+)-(3R), (4S), (5S), (7R)-3-hydroxy-5-.alpha.-hydroxybenzyl-1-methyl-4-phenyl-pyrrolidin-2-one and derivatives in the form of pure enantiomers.
Type:
Grant
Filed:
May 14, 1987
Date of Patent:
July 11, 1989
Assignees:
Bayer AG, Chinese Academy of Medical Sciences